Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.238 | 0.3713 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0042 | 0.6411 | 0.6187 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.2373 | 0.3702 |
Loa Loa (eye worm) | TAR-binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0042 | 0.6411 | 0.5 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0042 | 0.6411 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0042 | 0.6411 | 0.6187 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0034 | 0.4626 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0036 | 0.513 | 0.8002 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0042 | 0.6411 | 0.6187 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.002 | 0.1793 | 0.207 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0032 | 0.4166 | 0.5 |
Brugia malayi | TAR-binding protein | 0.006 | 1 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0042 | 0.6411 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.2885 | 0.4499 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0042 | 0.6411 | 1 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0042 | 0.6411 | 0.6187 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0014 | 0.0587 | 0.0916 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.238 | 0.3713 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0042 | 0.6411 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0034 | 0.4626 | 0.6934 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0018 | 0.1288 | 0.1204 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.238 | 0.3713 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0042 | 0.6411 | 0.6187 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3337 | 0.5205 |
Schistosoma mansoni | tar DNA-binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0014 | 0.0587 | 0.0916 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0042 | 0.6411 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.2885 | 0.4499 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0042 | 0.6411 | 0.5 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0042 | 0.6411 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.2833 | 0.4418 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0014 | 0.0587 | 0.0916 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.2885 | 0.4499 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.2373 | 0.3702 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0034 | 0.4626 | 0.6934 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0042 | 0.6411 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.4618 | 0.7204 |
Giardia lamblia | GTOR | 0.0042 | 0.6411 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.2373 | 0.3702 |
Echinococcus granulosus | tar DNA binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.4618 | 0.7204 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.4618 | 0.7204 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0042 | 0.6411 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.4618 | 0.7204 |
Echinococcus multilocularis | tar DNA binding protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.4618 | 0.7204 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3527 | 0.5501 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0014 | 0.0587 | 0.0916 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.238 | 0.3713 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0014 | 0.0587 | 0.0916 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.006 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0025 | 0.2833 | 0.4418 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0042 | 0.6411 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0032 | 0.4166 | 0.6498 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0 | Compound was evaluated for its ability to block conditioned avoidance response (CAR) in rats; Dose administered perorally is 10 mg/kg; no sinificant block 0-25% | ChEMBL. | 6105217 |
EDmin (functional) | = 12.5 mg kg-1 | Hypothermia in mice after perorla administration | ChEMBL. | 6105217 |
EDmin (functional) | = 12.5 mg kg-1 | Hypothermia in mice after perorla administration | ChEMBL. | 6105217 |
LD50 (ADMET) | = 150 mg kg-1 | Lethal dose in mice after perorla administration | ChEMBL. | 6105217 |
LD50 (ADMET) | = 150 mg kg-1 | Lethal dose in mice after perorla administration | ChEMBL. | 6105217 |
NT (functional) | 0 | compound was evaluated for its ability to produce catalepsy activity in rats; NT denotes not tested | ChEMBL. | 6105217 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.